Literature DB >> 20133075

Renal atrophy secondary to chemoradiotherapy of abdominal malignancies.

Gary Y Yang1, Kilian Salerno May, Renuka V Iyer, Rameela Chandrasekhar, Gregory E Wilding, Susan A McCloskey, Nikhil I Khushalani, Saikrishna S Yendamuri, John F Gibbs, Marwan Fakih, Charles R Thomas.   

Abstract

PURPOSE: To identify factors predictive of renal atrophy after chemoradiotherapy of gastrointestinal malignancies. METHODS AND MATERIALS: Patients who received chemotherapy and abdominal radiotherapy (RT) between 2002 and 2008 were identified for this study evaluating change in kidney size and function after RT. Imaging and biochemical data were obtained before and after RT in 6-month intervals. Kidney size was defined by craniocaudal measurement on CT images. The primarily irradiated kidney (PK) was defined as the kidney that received the greater mean kidney dose. Receiver operating characteristic (ROC) curves were generated to predict risk for renal atrophy.
RESULTS: Of 130 patients, median age was 64 years, and 51.5% were male. Most primary disease sites were pancreas and periampullary tumors (77.7%). Median follow-up was 9.4 months. Creatinine clearance declined 20.89%, and size of the PK decreased 4.67% 1 year after completion of chemoradiation. Compensatory hypertrophy of the non-PK was not seen. Percentage volumes of the PK receiving ≥10 Gy (V(10)), 15 Gy (V(15)), and 20 Gy (V(20)) were significantly associated with renal atrophy 1 year after RT (p = 0.0030, 0.0029, and 0.0028, respectively). Areas under the ROC curves for V(10), V(15), and V(20) to predict >5% decrease in PK size were 0.760, 0.760, and 0.762, respectively.
CONCLUSIONS: Significant detriments in PK size and renal function were seen after abdominal RT. The V(10), V(15), and V(20) were predictive of risk for PK atrophy 1 year after RT. Analyses suggest the association of lower-dose renal irradiation with subsequent development of renal atrophy. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133075     DOI: 10.1016/j.ijrobp.2009.07.1744

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies.

Authors:  Kilian Salerno May; Gary Y Yang; Nikhil I Khushalani; Rameela Chandrasekhar; Gregory E Wilding; Leayn Flaherty; Harish K Malhotra; Richard C Russo; John C Warner; Johnny C Yap; Renuka V Iyer; Chukwumere E Nwogu; Saikrishna S Yendamuri; John F Gibbs; Hector R Nava; Dominick Lamonica; Charles R Thomas
Journal:  J Gastrointest Oncol       Date:  2010-09

2.  Renal Function Outcomes of High-risk Neuroblastoma Patients Undergoing Radiation Therapy.

Authors:  Thomas H Beckham; Dana L Casey; Michael P LaQuaglia; Brian H Kushner; Shakeel Modak; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-11       Impact factor: 7.038

3.  Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes.

Authors:  Anis Ahmad; Alla Mitrofanova; Jacek Bielawski; Yidong Yang; Brian Marples; Alessia Fornoni; Youssef H Zeidan
Journal:  FASEB J       Date:  2016-11-11       Impact factor: 5.191

4.  Comparison of changes in renal function with dosimetric parameters in gastric cancer patients treated with adjuvant chemoradiotherapy.

Authors:  Nuri Kaydıhan; Kimia Çepni; Şefika Arzu Ergen; Mustafa Şükrü Şenocak; Didem Çolpan Öksüz
Journal:  Jpn J Radiol       Date:  2017-10-24       Impact factor: 2.374

5.  Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience.

Authors:  Nadia K Malik; Kilian Salerno May; Rameela Chandrasekhar; Wen Wee; Leayn Flaherty; Renuka Iyer; John Gibbs; Boris Kuvshinoff; Gregory Wilding; Graham Warren; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2012-12

Review 6.  Translational Aspects of Sphingolipid Metabolism in Renal Disorders.

Authors:  Alaa Abou Daher; Tatiana El Jalkh; Assaad A Eid; Alessia Fornoni; Brian Marples; Youssef H Zeidan
Journal:  Int J Mol Sci       Date:  2017-11-25       Impact factor: 5.923

7.  Volumetric decrease of pancreas after abdominal irradiation, it is time to consider pancreas as an organ at risk for radiotherapy planning.

Authors:  Cengiz Gemici; Gokhan Yaprak; Sevim Ozdemir; Tamer Baysal; Ozgur Ozan Seseogullari; Hazan Ozyurt
Journal:  Radiat Oncol       Date:  2018-12-03       Impact factor: 3.481

8.  Delayed renal dysfunction after total body irradiation in pediatric malignancies.

Authors:  Miho Watanabe Nemoto; Koichi Isobe; Gentaro Togasaki; Aki Kanazawa; Marie Kurokawa; Makoto Saito; Rintaro Harada; Hiroyuki Kobayashi; Hisao Ito; Takashi Uno
Journal:  J Radiat Res       Date:  2014-06-08       Impact factor: 2.724

9.  Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.

Authors:  Takaya Yamamoto; Noriyuki Kadoya; Ken Takeda; Haruo Matsushita; Rei Umezawa; Kiyokazu Sato; Masaki Kubozono; Kengo Ito; Yojiro Ishikawa; Maiko Kozumi; Noriyoshi Takahashi; Yu Katagiri; Hiroshi Onishi; Keiichi Jingu
Journal:  Radiat Oncol       Date:  2016-05-26       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.